Home » Achillion Gets Fast Track Designation for ACH-3102 to Treat Chronic Hepatitis C
Achillion Gets Fast Track Designation for ACH-3102 to Treat Chronic Hepatitis C
Achillion Pharmaceuticals announced the receipt of a fast track designation from the Food and Drug Administration for ACH-3102 as part of an interferon-free regimen for the treatment of chronic hepatitis C.
RTTnews
RTTnews
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May